Natalie Schroyens
Overview
Explore the profile of Natalie Schroyens including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
96
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Daes T, van den Hurk K, Schroyens N, Mikkelsen S, Severijns P, De Buck E, et al.
Transfus Med Rev
. 2024 Sep;
38(4):150851.
PMID: 39244430
Most plasma used for manufacturing plasma-derived medicinal products (PDMPs) such as albumin, immunoglobulin (Ig), and clotting factors is obtained from source plasma collected via plasmapheresis, the majority of which is...
2.
No evidence that post-training dopamine D2 receptor agonism affects fear generalization in male rats
Schroyens N, Vercammen L, Ozcan B, Ossorio Salazar V, Zaman J, De Bundel D, et al.
J Psychopharmacol
. 2024 Jul;
38(7):672-682.
PMID: 39068641
Background: The neurotransmitter dopamine plays an important role in the processing of emotional memories, and prior research suggests that dopaminergic manipulations immediately after fear learning can affect the retention and...
3.
Luyten L, Chalkia A, Schnell A, Ozcan B, Leng L, Schroyens N, et al.
J Anxiety Disord
. 2024 May;
104:102870.
PMID: 38733644
Exposure therapy is an evidence-based treatment option for anxiety-related disorders. Many patients also take medication that could, in principle, affect exposure therapy efficacy. Clinical and laboratory evidence indeed suggests that...
4.
Schroyens N, Daes T, De Buck E, Mikkelsen S, Tiberghien P, van den Hurk K, et al.
Vox Sang
. 2023 Oct;
119(2):110-120.
PMID: 37814964
Background And Objectives: As part of a large-scale project to safely increase plasma collection in Europe, the current scoping review identifies the existing evidence (gaps) on adverse events (AEs) and...
5.
Schroyens N, Borra V, Compernolle V, Vandekerckhove P, De Buck E
Vox Sang
. 2023 Jun;
118(9):709-720.
PMID: 37322809
Background And Objectives: This systematic review update summarizes evidence concerning transfusion-transmissible infections (TTIs) in male blood donors reporting sex with another man (MSM) or after easing the MSM deferral period....
6.
Schroyens N, Beckers T, Luyten L
Psychon Bull Rev
. 2022 Sep;
30(2):450-463.
PMID: 36085236
Re-exposure to elements of prior experiences can create opportunities for inducing amnesia for those events. The dominant theoretical framework posits that such re-exposure can result in memory destabilization, making the...
7.
Luyten L, Schnell A, Schroyens N, Beckers T
BMC Biol
. 2021 Jan;
19(1):17.
PMID: 33499865
Background: Long-term memory formation is generally assumed to involve the permanent storage of recently acquired memories, making them relatively insensitive to disruption, a process referred to as memory consolidation. However,...
8.
Schroyens N, Sigwald E, Van Den Noortgate W, Beckers T, Luyten L
eNeuro
. 2020 Dec;
8(1).
PMID: 33355289
Research on memory reconsolidation has been booming in the last two decades, with numerous high-impact publications reporting promising amnestic interventions in rodents and humans. However, our own recently-published failed replication...
9.
Chalkia A, Schroyens N, Leng L, Vanhasbroeck N, Zenses A, Van Oudenhove L, et al.
Cortex
. 2020 Jun;
129:496-509.
PMID: 32580869
It has been proposed that memory retrieval can destabilize consolidated memories, after which they need to be reconsolidated in order to be retained. The presentation of relevant information during memory...
10.
Schroyens N, Alfei J, Schnell A, Luyten L, Beckers T
Neurobiol Learn Mem
. 2019 Nov;
166:107105.
PMID: 31705982
With the ultimate goal of investigating boundary conditions for post-reactivation amnesia, we set out to replicate studies in which systemic, post-reactivation administration of midazolam, propranolol, or cycloheximide resulted in amnesia...